Evidence map›Paper›PMID 40851313›Full record

ArticleJMIR AI2025

Heterogeneity in Effects of Automated Results Feedback After Online Depression Screening: Secondary Machine-Learning Based Analysis of the DISCOVER Trial.

Matthias Klee, Byron C Jaeger, Franziska Sikorski, Bernd Löwe, Sebastian Kohlmann

Abstract read
In one paragraph

Article in JMIR AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthias KleeDepartment of General Internal Medicine and Psychosomatics, Heidelberg University, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany, 49 62215632879.ORCID http://orcid.org/0000-0002-1629-482X
Byron C JaegerDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.ORCID http://orcid.org/0000-0001-7399-2299
Franziska SikorskiDepartment of Psychosomatic Medicine & Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0003-1191-5073
Bernd LöweDepartment of Psychosomatic Medicine & Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0003-4220-3378
Sebastian KohlmannDepartment of General Internal Medicine and Psychosomatics, Heidelberg University, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany, 49 62215632879.ORCID http://orcid.org/0000-0003-1307-4618

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Online depression screening tools may increase uptake of evidence-based care and consequently lead to symptom reduction. However, results of the DISCOVER trial suggested no effect of automated results feedback compared with no feedback after online depression screening on depressive symptom reduction six months after screening. Interpersonal variation in symptom representation, health care needs, and treatment preferences may nonetheless have led to differential response to feedback mode on an individual level. Objective: The aim of this study was to examine heterogeneity of treatment effects (HTE), that is, differential responses to two feedback modes (tailored or nontailored) versus no feedback (control) following online depression screening. Methods: We used causal forests, a machine learning method that applies recursive partitioning to estimate conditional average treatment effects (CATEs). In this secondary data analysis of the DISCOVER trial, eligible participants screened positive for at least moderate depression severity but had not been diagnosed or treated for depression in the preceding year. The primary outcome was heterogeneity in depression severity change, over a and six-month follow up period, measured with the Patient Health Questionnaire-9. Analysis comprised exploration of average treatment effects (ATE), HTE, operationalized with the area under the targeting operator characteristic curve (AUTOC), and differences in ATE when allocating feedback based on predicted CATE. We extracted top predictors of depression severity change, given feedback and explored high-CATE covariate profiles. Prior to analysis, data was split into training and test sets (1:1) to minimize the risk of overfitting and evaluate predictions in held-out test data. Results: Data from 946 participants of the DISCOVER trial without missing data were analyzed. We did not detect HTE; no versus nontailored feedback, AUTOC -0.48 (95% CI -1.62 to 0.67, P=.41); no versus tailored feedback, AUTOC 0.06 (95% CI -1.21 to 1.33, P=.93); and no versus any feedback, AUTOC -0.20 (95% CI -1.30 to 0.89, P=.72). There was no evidence of alteration to the ATE in the test set when allocating feedback (tailored or nontailored) based on the predicted CATE. By examining covariate profiles, we observed a potentially detrimental role of control beliefs, given feedback compared with no feedback. Conclusions: We applied causal forests to describe higher-level interactions among a broad range of predictors to detect HTE. In absence of evidence for HTE, treatment prioritization based on trained models did not improve ATEs. We did not find evidence of harm or benefit from providing tailored or nontailored feedback after online depression screening regarding depression severity change after six months. Future studies may test whether screening alone prompts behavioral activation and downstream depression severity reduction, considering the observed uniform changes across groups.

Indexed as

causal random forestdepressiondepression screeningDISCOVERfeedbackheterogeneity of treatment effectsrandom foresttreatment heterogeneity

Identifiers

PMID40851313
PMCPMC12375799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.